(Q44100959)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411418%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411418%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411418%20AND%20SRC:MED&resulttype=core&format=json

Mauro Giuseppe Mastropasqua

23 February 2020

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411418%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Marco Colleoni

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411418%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

E Montagna

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411418%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

V Bagnardi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411418%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

G Viale

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411418%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

N Rotmensz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411418%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

A Sporchia

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411418%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

G Cancello

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411418%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

A Balduzzi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411418%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

V Galimberti

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411418%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

A Luini

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411418%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

C Casadio

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411418%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

C Sangalli

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411418%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

A Goldhirsch

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411418%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

publication date

19 November 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411418%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411418%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411418%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411418%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

307-313

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411418%20AND%20SRC:MED&resulttype=core&format=json

Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors.

23 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU528

Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU528

HER-2/neu expression in primary and metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU528

Breast cancer subtypes and outcome after local and regional relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU528

Prognostic value of a positive-to-negative change in hormone receptor status after neoadjuvant chemotherapy in patients with hormone receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU528

Loss of HER2 amplification following trastuzumab-based neoadjuvant systemic therapy and survival outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU528

A prognostic model based on combining estrogen receptor expression and Ki-67 value after neoadjuvant chemotherapy predicts clinical outcome in locally advanced breast cancer: extension and analysis of a previously reported cohort of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU528

Ki67 measured after neoadjuvant chemotherapy for primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU528

Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU528

Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU528

Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU528

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU528

Molecular profiles of progesterone receptor loss in human breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU528

Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU528

Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU528

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDU528

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25411418%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference